You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 3, January 21, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Users' Guides to the Medical Literature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Alzheimer Disease
 •Patient-Physician Relationship/ Care
 •Patient-Physician Communication
 •Statistics and Research Methods
 •Genetics
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

How to Use an Article About Genetic Association

C: What Are the Results and Will They Help Me in Caring for My Patients?

John Attia, MD, PhD; John P. A. Ioannidis, MD, PhD; Ammarin Thakkinstian, PhD; Mark McEvoy, MMedSc; Rodney J. Scott, PhD; Cosetta Minelli, PhD; John Thompson, PhD; Claire Infante-Rivard, MD, PhD; Gordon Guyatt, MD, MSc

JAMA. 2009;301(3):304-308.

In the first 2 articles of this series, we reviewed the basic genetics concepts necessary to understand genetic association studies, and we enumerated the major issues in judging the validity of these studies. In this third article, we review the issues relating to the applicability of the results in the clinical situation. How large and precise are the associations? Many genetic effects are expected to be smaller in magnitude than traditional risk factors. Does the genetic association improve predictive power beyond easily measured clinical variables? In some cases, the additional genetic information adds only a small increment in the predictive ability of a diagnostic or prognostic test. What are the absolute vs relative effects? Even if the genetic risk is high in relative terms, the baseline risk may be very low in absolute terms. Is the risk-associated allele likely to be present in my patient? A risk allele may have a strong effect but be rare in a particular ethnic group. Is the patient likely better off knowing the genetic information? Given that genes cannot be modified, one must weigh whether the genetic information is likely to be helpful in planning other health interventions or initiating behavior change.


Author Affiliations: Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Hunter Medical Research Institute, and Department of General Medicine, John Hunter Hospital, Newcastle, Australia (Dr Attia); Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece, and Center for Genetic Epidemiology and Modeling, Tufts Medical Center, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts (Dr Ioannidis); Clinical Epidemiology Unit, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (Dr Thakkinstian); Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia (Mr McEvoy); Division of Genetics, Hunter Area Pathology Service, John Hunter Hospital, New Lambton, Australia, and Centre for Information Based Medicine, Faculty of Health, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia (Dr Scott); Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, England (Dr Minelli); Department of Health Sciences, University of Leicester, Leicester, England (Dr Thompson); Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Canada (Dr Infante-Rivard); and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada (Dr Guyatt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atoms
Bauchner
Arch. Dis. Child. 2009;94:i-i.
FULL TEXT  

Reviews of Note
JWatch Psychiatry 2009;2009:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.